Blindsight is an experimental medical device developed by Neuralink.[1][2] It has received Breakthrough Device Designation from the US Food and Drugs Administration (FDA).[3][4]
| Inception | September 2024  |
|---|
Purpose
editBlindsight is being developed to enable individuals with total visual impairment due to damage to the optic nerve but with intact visual cortex to see, this is made possible by bypassing the optic nerve and directly stimulating the visual cortex to create a visual perception.[5][6]
References
edit- ^ "Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant". Reuters. 2024-09-17. Retrieved 2024-09-18.
- ^ "Elon Musk's Neuralink gets FDA breakthrough device tag for 'Blindsight' implant". The Economic Times. 2024-09-18. Retrieved 2024-09-18.
- ^ Gowran, Leigh Mc (2024-09-18). "Neuralink's 'blindsight' implant gets key FDA designation". Silicon Republic. Retrieved 2024-09-18.
- ^ Sinha, Sujita (2024-09-18). "US: Elon Musk's vision-restoring tech gains FDA 'breakthrough' tag". Interesting Engineering. Retrieved 2024-09-18.
- ^ Barrabi, Thomas (2024-09-18). "Elon Musk's Neuralink brain chip receives FDA's 'breakthrough device' status". New York Post. Retrieved 2024-09-18.
- ^ Sharma, Divyanshi (2024-09-18). "Those who have been blind from birth will get to see the world with Elon Musk's Neuralink Blindsight: All you need to know". Business Insider. Retrieved 2024-09-18.
 | This article related to medical equipment is a stub. You can help Wikipedia by expanding it. |